论文信息 - Biopharmaceutical Manufacturing: Historical and Future Trends in Titers, Yields, and Efficiency in Commercial-Scale Bioprocessing - 字舞流文

Biopharmaceutical Manufacturing: Historical and Future Trends in Titers, Yields, and Efficiency in Commercial-Scale Bioprocessing

Ronald Rader | Eric Langer | R. Rader | E. Langer

[1] F. Wurm. Manufacture of Recombinant Biopharmaceutical Proteins by Cultivated Mammalian Cells in Bioreactors , 2008 .

[2] Brian Kelley,et al. Industrialization of mAb production technology: The bioprocessing industry at a crossroads , 2009, mAbs.

[3] R. Rader. An Analysis of the US Biosimilars Development Pipeline and Likely Market Evolution , 2013 .

[4] F. Wurm,et al. 25 years of recombinant proteins from reactor-grown cells - where do we go from here? , 2009, Biotechnology advances.